QIAGEN N.V. (QGEN) Stock News

NYSE:QGEN - New York Stock Exchange, Inc. - NL0015002CX3 - Common Stock - Currency: USD

50.57 -0.5 (-0.98%)

After market: 50.57 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

QGEN Latest News, Press Relases and Analysis

All

Press Releases

10 days ago - By: Chartmill

News Image

QIAGEN N.V. (NYSE:QGEN) - A Strong Technical Setup for Breakout Investors

8 days ago - By: QIAGEN N.V.

QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels

23 days ago - By: QIAGEN N.V.

QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast

a month ago - By: QIAGEN N.V..

QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board

a month ago - By: Yahoo Finance - Mentions: INCY ILMN VRNA

Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions

a month ago - By: Zacks Investment Research

Here's Why Qiagen (QGEN) is a Strong Growth Stock

a month ago - By: QIAGEN N.V.

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership

2 months ago - By: Yahoo Finance - Mentions: GS INCY RY RY.CA ...

Incyte (INCY) Targets $1B Growth by 2029 with New Drug Launches

2 months ago - By: QIAGEN N.V. - Mentions: INCY

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)

2 months ago - By: Zacks Investment Research - Mentions: INCY

Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue?

2 months ago - By: Zacks Investment Research - Mentions: COR PAHC HIMS

QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances

2 months ago - By: Yahoo Finance - Mentions: VZ ASC

KeyBank adopts Personetics platform to enhance client engagement

2 months ago - By: QIAGEN N.V.

QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships

2 months ago - By: Foresight Diagnostics, Inc.

Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma

2 months ago - By: Yahoo Finance - Mentions: MRNA TGT RIO TSLA

Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research

2 months ago - By: Zacks Investment Research - Mentions: ANGO DXCM STE

QGEN Stock Might Gain Following New Partnership With ID Solutions

2 months ago - By: QIAGEN N.V.

QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions

3 months ago - By: Zacks Investment Research

Here's Why Qiagen (QGEN) is a Strong Momentum Stock

3 months ago - By: Zacks Investment Research

Here's Why Qiagen (QGEN) is a Strong Value Stock

3 months ago - By: Zacks Investment Research - Mentions: ANGO DXCM STE

QIAGEN Stock Gains Following the Acquisition of Genoox

3 months ago - By: QIAGEN N.V.

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

3 months ago - By: Zacks Investment Research - Mentions: BSX ANGO ITGR

QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up

3 months ago - By: Zacks Investment Research

Here's What Key Metrics Tell Us About Qiagen (QGEN) Q1 Earnings

3 months ago - By: Zacks Investment Research - Mentions: YMAB

Qiagen (QGEN) Q1 Earnings and Revenues Surpass Estimates

3 months ago - By: QIAGEN N.V.

QIAGEN announces plans for transition in leadership of Supervisory Board

3 months ago - By: QIAGEN N.V.

QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase

3 months ago - By: QIAGEN N.V.

QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting

3 months ago - By: Benzinga - Mentions: XPER EMR BLZE ERII ...

Earnings Scheduled For May 7, 2025

3 months ago - By: Zacks Investment Research

Stay Ahead of the Game With Qiagen (QGEN) Q1 Earnings: Wall Street's Insights on Key Metrics

3 months ago - By: Zacks Investment Research - Mentions: ADPT

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: SGMO

Sangamo Therapeutics (SGMO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

3 months ago - By: Zacks Investment Research - Mentions: ARQT

Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth

3 months ago - By: QIAGEN N.V.

QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control

3 months ago - By: Zacks Investment Research

Why Qiagen (QGEN) is a Top Value Stock for the Long-Term

3 months ago - By: QIAGEN N.V.

QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025